Turner E E, Fedtsova N, Jeste D V
Department of Psychiatry, University of California, San Diego, USA.
Schizophr Res. 1997 Oct 30;27(2-3):169-80. doi: 10.1016/S0920-9964(97)00067-4.
Schizophrenia is in essence a developmental disorder, but an unusual one in that the onset of symptoms is markedly delayed. Neuropathologic studies of the brain in schizophrenia have revealed subtle abnormalities that may reflect abnormal neuronal development. A more detailed examination of the cellular and molecular pathology of schizophrenia has been limited by the lack of informative markers that might allow a more complete understanding of the brain defects that characterize this disorder. Recent advances in molecular biology have made available a growing number of probes for examining the expression of specific gene products in brain tissue by using in situ hybridization and immunohistochemistry using antibodies to recombinant antigens. Several recently cloned neural genes are expressed in the forebrain regions which have been implicated in schizophrenia, and may have significant roles in brain development or function. Selected neurotransmitter receptors, neurotrophins and their receptors, and transcription factors of the POU and MADS families are promising candidates for future studies of the cellular and molecular neuropathology of schizophrenia.
精神分裂症本质上是一种发育障碍,但却是一种不寻常的发育障碍,因为其症状的出现明显延迟。对精神分裂症患者大脑的神经病理学研究已经揭示了一些细微的异常,这些异常可能反映了神经元发育异常。由于缺乏能够更全面理解该疾病所特有的脑缺陷的信息性标志物,对精神分裂症细胞和分子病理学的更详细研究受到了限制。分子生物学的最新进展使得通过原位杂交和使用针对重组抗原的抗体进行免疫组织化学来检测脑组织中特定基因产物的表达的探针越来越多。最近克隆的几个神经基因在前脑区域表达,这些区域与精神分裂症有关,并且可能在大脑发育或功能中发挥重要作用。选定的神经递质受体、神经营养因子及其受体,以及POU和MADS家族的转录因子是未来精神分裂症细胞和分子神经病理学研究的有希望的候选对象。